Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Earnings call Dr. Lal PathLabs reported Q2 FY26 revenue of ₹731 crore, up 10.7% YoY, with PAT rising 16.4% to ₹152 crore and EBITDA margin stable at 30.7%. Management reaffirmed FY26 revenue growth ...

Explore DR LAL PATH LABS F stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the highest ...

This page features the latest DR LAL PATH LABS F share stories and breaking news. Assess the latest information about the DR LAL PATH LABS F stock. Our team of expert financial journalists are ready ...

Add Yahoo as a preferred source to see more of our stories on Google. Jan 30 (Reuters) - Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...

April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...

Discover Dr Lal Path Labs diagnostic services in New Delhi, Delhi. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...

Discover Dr Lal Path Labs diagnostic services in Gurgaon, Haryana. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...

Earnings call Dr. Lal PathLabs reported FY25 revenue of ₹2,461 crore, up 10.5% YoY, with PAT rising 35.9% to ₹492 crore (including a one-time tax benefit). Q4 margins expanded, but FY26 guidance ...

Bengaluru: Dr. Lal Path Labs reported a ‍lower third-quarter profit on Friday after taking a one-time charge ⁠linked to India's new labour code, despite strong demand for its bundled test packages.